APA (7th ed.) Citation

Tahmasvand, R., Dehghani, S., Kooshafar, Z., Emami Najafi, S. A., Almasirad, A., & Salimi, M. (2024). In vitro and in vivo activity of a novel oxamide-hydrazone hybrid derivative against triple-negative breast cancer. Naunyn-Schmiedeberg's archives of pharmacology, 397(7), 5119-5129. https://doi.org/10.1007/s00210-023-02931-6

Chicago Style (17th ed.) Citation

Tahmasvand, Raheleh, Soudeh Dehghani, Zahra Kooshafar, Seyedeh Azadeh Emami Najafi, Ali Almasirad, and Mona Salimi. "In Vitro and in Vivo Activity of a Novel Oxamide-hydrazone Hybrid Derivative Against Triple-negative Breast Cancer." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 7 (2024): 5119-5129. https://doi.org/10.1007/s00210-023-02931-6.

MLA (9th ed.) Citation

Tahmasvand, Raheleh, et al. "In Vitro and in Vivo Activity of a Novel Oxamide-hydrazone Hybrid Derivative Against Triple-negative Breast Cancer." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 7, 2024, pp. 5119-5129, https://doi.org/10.1007/s00210-023-02931-6.